Retatrutide
Triple-agonist metabolic research peptide targeting GLP-1, GIP and glucagon receptors.
- Purity:
- ≥99% HPLC
- Sizes available:
- 10 mg
29 compounds we source and verify, each with the certificate of analysis for its lot. Prices and direct checkout for every compound we ship are on the pricing page.
29 compounds
Triple-agonist metabolic research peptide targeting GLP-1, GIP and glucagon receptors.
BPC-157 and TB-500 in a single vial — the pairing most studied together in tissue-repair research.
Growth hormone-releasing hormone analogue used in endocrine signalling research.
Copper-binding tripeptide studied in extracellular matrix and dermal research models.
Essential redox cofactor central to cellular metabolism and sirtuin research.
Modified GRF(1-29) tetrasubstituted analogue without drug affinity complex.
Selective ghrelin receptor (GHS-R1a) agonist pentapeptide.
Stabilised GHRH(1-44) analogue studied in adipose tissue distribution research.
Melanocortin receptor agonist studied in central nervous system signalling.
Bacteriostatic water with lidocaine, 6 mL, for reconstitution.
Dual GIP and GLP-1 receptor agonist, the molecule in Mounjaro and Zepbound.
GLP-1 receptor agonist, the molecule in Ozempic and Wegovy.
Long-acting amylin analogue, the cagrilintide half of CagriSema.
Mitochondria-targeted tetrapeptide that binds cardiolipin, also called elamipretide.
28-amino-acid thymic peptide studied as an immune modulator; synthetic form thymalfasin.
Cyclic α-MSH analogue that activates several melanocortin receptors.
GHK-Cu, TB-500 and BPC-157 together in one vial.
No compounds match this filter.
| Compound | Also known as | Classification | Research area | Purity | Vial sizes |
|---|---|---|---|---|---|
| Retatrutide | LY3437943, Reta, triple agonist GLP-1/GIP/glucagon | Triple GLP-1 / GIP / glucagon receptor agonist | Metabolic research | ≥99% HPLC | 10 mg |
| Sermorelin | GRF (1-29), GHRH (1-29), Geref | GHRH (1-29) analogue | Growth hormone axis | ≥99% HPLC | 5 mg, 10 mg, 20 mg |
| GHK-Cu (Copper Peptide) | GHK-Cu, copper peptide, copper tripeptide-1, Gly-His-Lys copper | Gly-His-Lys tripeptide copper(II) complex | Tissue & repair | ≥99% HPLC | 50 mg Normal, 50 mg Plus |
| NAD+ (Nicotinamide Adenine Dinucleotide) | NAD+, NAD plus, nicotinamide adenine dinucleotide | Nicotinamide adenine dinucleotide | Longevity & cellular | ≥99% HPLC | 250 mg Raw Powder, 300 mg |
| BPC-157 + TB-500 | Body Protection Compound 157, BPC157, Pentadecapeptide BPC 157, PL 14736, TB500, thymosin beta-4, thymosin beta 4 fragment, TB4 | Pentadecapeptide BPC (1-15) + thymosin β4 active fragment (17-23) | Tissue & repair | ≥99% HPLC | 5 mg + 5 mg |
| MOTS-c | MOTSc, mitochondrial ORF of the 12S rRNA type-c | Mitochondrial-derived peptide, 16 aa | Metabolic research | ≥99% HPLC | 10 mg, 20 mg |
| CJC-1295 (sin DAC) | Modified GRF 1-29, Mod GRF (1-29) | Modified GRF (1-29), no DAC | Growth hormone axis | ≥99% HPLC | 5 mg, 10 mg, 20 mg |
| Ipamorelin | NNC 26-0161 | Pentapeptide GHS-R1a agonist | Growth hormone axis | ≥99% HPLC | 5 mg, 10 mg, 20 mg |
| Tesamorelin | TH9507, Egrifta | Trans-3-hexenoyl GHRH (1-44) analogue | Growth hormone axis | ≥99% HPLC | 10 mg, 20 mg |
| PT-141 (Bremelanotide) | PT141, bremelanotide | Melanocortin receptor agonist, cyclic heptapeptide | Neurological research | ≥99% HPLC | 5 mg, 10 mg |
| Epitalon | Epithalon, Epithalamin, AEDG peptide, Ala-Glu-Asp-Gly | Ala-Glu-Asp-Gly tetrapeptide | Longevity & cellular | ≥99% HPLC | 20 mg |
| KPV | Lys-Pro-Val, alpha-MSH (11-13) fragment | Lys-Pro-Val tripeptide, α-MSH (11-13) | Tissue & repair | ≥99% HPLC | 5 mg, 10 mg, 20 mg |
| Semax | Met-Glu-His-Phe-Pro-Gly-Pro, ACTH (4-10) analogue | ACTH (4-10) analogue, heptapeptide | Neurological research | ≥99% HPLC | 5 mg, 10 mg, 20 mg |
| Selank | TP-7, tuftsin analogue | Tuftsin analogue, heptapeptide | Neurological research | ≥99% HPLC | 5 mg, 10 mg, 20 mg |
| Pinealon | Glu-Asp-Arg, EDR peptide | Glu-Asp-Arg tripeptide | Longevity & cellular | ≥99% HPLC | 10 mg, 20 mg |
| BAC Water+ (6mL con Lidocaína) | bacteriostatic water with lidocaine, BAC water plus | 0.9% benzyl alcohol + lidocaine, 6 mL | Laboratory supplies | USP grade | 6 mL |
| Vesugen | Lys-Glu-Asp, KED peptide | Lys-Glu-Asp tripeptide | Longevity & cellular | ≥99% HPLC | 10 mg, 20 mg |
| Agua BAC | bacteriostatic water, BAC water, 0.9% benzyl alcohol water | 0.9% benzyl alcohol, 30 mL | Laboratory supplies | USP grade | 30 mL |
| Tirzepatide | LY3298176 | Dual GIP / GLP-1 receptor agonist, 39-amino-acid peptide | Metabolic research | ≥99% HPLC | 15 mg, 30 mg |
| Semaglutide | — | GLP-1 receptor agonist, acylated GLP-1 analogue | Metabolic research | ≥99% HPLC | 5 mg |
| Cagrilintide | — | Long-acting acylated amylin analogue | Metabolic research | ≥99% HPLC | 5 mg |
| CagriSema | cagrilintide-semaglutide, cagrilintide and semaglutide | Cagrilintide + semaglutide, 5 mg + 5 mg in one vial | Metabolic research | ≥99% HPLC | 5 mg + 5 mg |
| SS-31 (Elamipretide) | Elamipretide, MTP-131, Bendavia | Mitochondria-targeted tetrapeptide, D-Arg-Dmt-Lys-Phe-NH2 | Longevity & cellular | ≥99% HPLC | 50 mg |
| Thymosin Alpha-1 | Thymalfasin, Tα1, thymosin alpha 1 | 28-amino-acid thymic peptide, N-terminally acetylated | Tissue & repair | ≥99% HPLC | 10 mg |
| IGF-1 LR3 | Long R3 IGF-1, LR3 IGF-1 | Long R3 IGF-1, 83-amino-acid IGF-1 analogue | Growth hormone axis | ≥99% HPLC | 1 mg |
| Melanotan II | MT-II, MT2, Melanotan 2 | Cyclic α-MSH analogue, melanocortin receptor agonist | Tissue & repair | ≥99% HPLC | 10 mg |
| GLOW (GHK-Cu + TB-500 + BPC-157) | GLOW blend, GLOW peptide | Three-peptide blend: GHK-Cu 50 mg + TB-500 10 mg + BPC-157 10 mg | Tissue & repair | ≥99% HPLC | 50 mg + 10 mg + 10 mg |
| Oxytocin | — | Cyclic nonapeptide hormone (disulfide ring) | Neurological research | ≥99% HPLC | 5 mg |
| DSIP | delta sleep-inducing peptide | Delta sleep-inducing peptide, Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu | Neurological research | ≥99% HPLC | 5 mg |